| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2011 | WO2011088181A1 Compounds and methods |
| 07/21/2011 | WO2011088152A1 Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof |
| 07/21/2011 | WO2011088140A1 Pegylated opioids with low potential for abuse and side effects |
| 07/21/2011 | WO2011088055A2 Methods and compositions for treating cardiovascular disorders |
| 07/21/2011 | WO2011088045A1 Aurora kinase compounds and methods of their use |
| 07/21/2011 | WO2011088015A1 Compounds which modulate the cb2 receptor |
| 07/21/2011 | WO2011087823A1 Aldehydes for in vivo imaging of aldh in cancer stem cells |
| 07/21/2011 | WO2011087812A1 Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective m1 agonists and methods of making and using same |
| 07/21/2011 | WO2011087791A1 3-keto-n-propargyl-1-aminoindan |
| 07/21/2011 | WO2011087790A1 Triple combination for lowering intraocular pres sure |
| 07/21/2011 | WO2011087776A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 07/21/2011 | WO2011087758A1 Adamantyl amide derivatives and uses of same |
| 07/21/2011 | WO2011087740A1 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases |
| 07/21/2011 | WO2011087738A2 1,4-substituted piperazine derivatives and methods of use thereof |
| 07/21/2011 | WO2011087713A2 Tricyclic derivatives and their pharmaceutical use and compositions |
| 07/21/2011 | WO2011087712A2 Tricyclic derivatives and their pharmaceutical use and compositions |
| 07/21/2011 | WO2011087654A1 Paxillin stimulating compositions and cosmetic uses thereof |
| 07/21/2011 | WO2011087652A1 Tropinone benzylamines as beta-tryptase inhibitors |
| 07/21/2011 | WO2011087464A1 Sustained release tablet formulation containing etodolac |
| 07/21/2011 | WO2011087441A1 A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties |
| 07/21/2011 | WO2011087187A1 Composition for protecting fetal nerve cells comprising vitamin c |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011087051A1 Therapeutic agent for atherosclerosis comprising s1p2 receptor antagonist |
| 07/21/2011 | WO2011087009A1 Regulatory gene controlling saccharometabolism, lipid metabolism, obesity and life, protein, and screening method |
| 07/21/2011 | WO2011087006A1 Pigmentation-preventing or -ameliorating agent |
| 07/21/2011 | WO2011086568A1 Controlled release composition for lamotrigine |
| 07/21/2011 | WO2011086541A1 Novel polymorph of nilotinib monohydrochloride monohydrate |
| 07/21/2011 | WO2011086532A1 New lipo-phosphated or lipo-sulphated compound, compositions comprising it and topical uses thereof |
| 07/21/2011 | WO2011086531A2 New anti-malarial agents |
| 07/21/2011 | WO2011086507A1 "compositions comprising amino acids for prevention and/or treatment of renal disorders" |
| 07/21/2011 | WO2011086470A1 Treatment of multiple sclerosis |
| 07/21/2011 | WO2011086425A1 Method for producing reservoir layer for hoof treatment and reservoir layer |
| 07/21/2011 | WO2011086424A1 Pharmaceutical use of multicyclic compounds mixtures as concomitant anti-cancer, anti-inflammatory and anti-pain agents |
| 07/21/2011 | WO2011086423A1 Pharmaceutical use of multicyclic compounds as anti-aids agents |
| 07/21/2011 | WO2011086399A1 Process for the preparation of strontium ranelate |
| 07/21/2011 | WO2011086377A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS |
| 07/21/2011 | WO2011086347A1 Pyrrolidine iminosugars used in the treatment of cystic fibrosis |
| 07/21/2011 | WO2011086322A1 Proteins interacting with gcp3 and uses thereof |
| 07/21/2011 | WO2011086321A1 Method for preparing polybiotinylated compounds |
| 07/21/2011 | WO2011086307A1 Pyrrolopyridine derivatives as nurr1 activators useful for treating parkinson's disease |
| 07/21/2011 | WO2011086306A1 5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases |
| 07/21/2011 | WO2011086194A1 Improved oral lysophilisates containing pvp/va |
| 07/21/2011 | WO2011086193A1 Oral lyophilized compositions |
| 07/21/2011 | WO2011086178A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7 |
| 07/21/2011 | WO2011086163A1 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors |
| 07/21/2011 | WO2011086146A1 Halogenated ether complex |
| 07/21/2011 | WO2011086134A1 Treatment of chlamydiaceae infections by means of beta-lactams |
| 07/21/2011 | WO2011086127A1 Process to make uv radiation absorbing 2 - phenyl - 1, 2, 3 - benzotriazoles |
| 07/21/2011 | WO2011086126A1 Compounds for the treatment of autism |
| 07/21/2011 | WO2011086125A1 1H-[1,2,3]TRIAZOLO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES |
| 07/21/2011 | WO2011086124A1 2 - phenyl - 1, 2, 3 - benzotriazoles for uv radiation absorbance |
| 07/21/2011 | WO2011086099A1 Novel substituted triazole derivatives as gamma secretase modulators |
| 07/21/2011 | WO2011086098A1 Novel substituted bicyclic triazole derivatives as gamma secretase modulators |
| 07/21/2011 | WO2011086085A1 Thiazole and oxazole kinase inhibitors |
| 07/21/2011 | WO2011086081A1 2,5-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | WO2011086080A1 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086079A1 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086078A1 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086075A1 2,5,7-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | WO2011086053A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| 07/21/2011 | WO2011086047A1 Method for titrating clozapine |
| 07/21/2011 | WO2011085990A1 Anti - infective pyrido (1,2 -a) pyrimidines |
| 07/21/2011 | WO2011085981A1 Arene chromium-carbonyl complexes, a method for the preparation of and us of as pharmaceutical |
| 07/21/2011 | WO2011085979A1 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions |
| 07/21/2011 | WO2011085886A1 Pyrrolidine derivatives |
| 07/21/2011 | WO2011085701A1 Stable protein kinase activators, preparation methods and uses thereof |
| 07/21/2011 | WO2011085643A1 Fused pyridine derivatives |
| 07/21/2011 | WO2011085641A1 Certain chemical entities, compositions, and methods |
| 07/21/2011 | WO2011085640A1 Colchiceinamide hydrates, preparation methods thereof, and uses thereof |
| 07/21/2011 | WO2011085606A1 Optically active compound of prulifloxacin for treating infection and preparation method thereof |
| 07/21/2011 | WO2011085544A1 Compounds which effecttively remove tumor or cancer cell |
| 07/21/2011 | WO2011085523A1 18-member or 14-member macrolides epothilone compounds and use thereof |
| 07/21/2011 | WO2011085474A1 Apparatus and method for delivering honey bee brood pheromone into a hive |
| 07/21/2011 | WO2011085473A1 Treating cancer with statins and compounds having dipyridamole activity |
| 07/21/2011 | WO2011085454A1 Gp120 -binding benzene compounds and saccharide compounds |
| 07/21/2011 | WO2011064296A9 Pharmaceutical compositions comprising sigma receptor ligands |
| 07/21/2011 | WO2011061330A3 Use of physiological cooling active ingredients, and agents containing such active ingredients |
| 07/21/2011 | WO2011054893A3 Biomarkers predictive of progression of fibrosis |
| 07/21/2011 | WO2011051264A3 Method of treatment |
| 07/21/2011 | WO2011050163A9 Method of preventing type 1 diabetes |
| 07/21/2011 | WO2011045775A4 A delayed release pharmaceutical composition of mesalamine |
| 07/21/2011 | WO2011037833A3 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents |
| 07/21/2011 | WO2011034919A3 Sh2 domain profiling to characterize tyrosine phosphorylation signaling in cancer |
| 07/21/2011 | WO2011033361A3 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic |
| 07/21/2011 | WO2011032896A3 Encapsulation using wax-type substances |
| 07/21/2011 | WO2011032169A3 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| 07/21/2011 | WO2011031884A3 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 07/21/2011 | WO2011031503A3 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10) |
| 07/21/2011 | WO2011031018A3 Water-soluble drug delivery system allowing slow release |
| 07/21/2011 | WO2011028941A3 Disabling autophagy as a treatment for lysosomal storage diseases |
| 07/21/2011 | WO2011028935A3 Methods of treating mitochondrial disorders using metalloporhyrins |
| 07/21/2011 | WO2011028860A3 Compounds and compositions for treating cancer |
| 07/21/2011 | WO2011028794A3 Treatment of huntington's disease with cycloserine and an nmda receptor antagonist |
| 07/21/2011 | WO2011028542A3 Methods of treating pain associated with complex regional pain syndrome |
| 07/21/2011 | WO2011028044A3 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 07/21/2011 | WO2011028043A3 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 07/21/2011 | WO2011027988A3 Novel polymorphic form of prasugrel-hydrogen sulfate |
| 07/21/2011 | WO2011026041A9 Sdf-1 delivery for treating ischemic tissue |
| 07/21/2011 | WO2011025932A3 Preparation of sitagliptin and salts thereof |